Coxibs: Evolution of a Revolutionary ClassApril 1, 2002RheumatologyGastroenterologyNephrologyCardiology
Development and clinical application of COX-2–selective inhibitors for the treatment of osteoarthritis and rheumatoid arthritisApril 1, 2002
Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2–selective inhibitorsApril 1, 2002
Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathyApril 1, 2002
